A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential

被引:106
作者
Lewis, I [1 ]
Bauer, W [1 ]
Albert, R [1 ]
Chandramouli, N [1 ]
Pless, J [1 ]
Weckbecker, G [1 ]
Bruns, C [1 ]
机构
[1] Novartis Pharma, Transplantat Res Dept, CH-4002 Basel, Switzerland
关键词
D O I
10.1021/jm021093t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A rational drug design approach, capitalizing on structure-activity relationships and involving transposition of functional groups from somatotropin release inhibitory factor (SRIF) into a reduced size cyclohexapeptide template, has led to the discovery of SOM230 (25), a novel, stable cyclohexapeptide somatostatin mimic that exhibits unique high-affinity binding to human somatostatin receptors (subtypes sst1-sst5). SOM230 has potent, long-lasting inhibitory effects on growth hormone and insulin-like growth factor-1 release and is a promising development candidate currently under evaluation in phase I clinical trials.
引用
收藏
页码:2334 / 2344
页数:11
相关论文
共 44 条
[1]  
BAUER W, 1980, LIFE SCI, V31, P1134
[2]   A COMPARISON OF ACID LABILE LINKAGE AGENTS FOR THE SYNTHESIS OF PEPTIDE C-TERMINAL AMIDES [J].
BERNATOWICZ, MS ;
DANIELS, SB ;
KOSTER, H .
TETRAHEDRON LETTERS, 1989, 30 (35) :4645-4648
[3]   HYPOTHALAMIC POLYPEPTIDE THAT INHIBITS SECRETION OF IMMUNOREACTIVE PITUITARY GROWTH-HORMONE [J].
BRAZEAU, P ;
VALE, W ;
BURGUS, R ;
LING, N ;
BUTCHER, M ;
RIVIER, J ;
GUILLEMIN, R .
SCIENCE, 1973, 179 (4068) :77-79
[4]   SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile [J].
Bruns, C ;
Lewis, I ;
Briner, U ;
Meno-Tetang, G ;
Weckbecker, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 146 (05) :707-716
[5]  
BRUNS C, 1995, CIBA F SYMP, V190, P89
[6]   MOLECULAR PHARMACOLOGY OF SOMATOSTATIN-RECEPTOR SUBTYPES [J].
BRUNS, C ;
WECKBECKER, G ;
RAULF, F ;
KAUPMANN, K ;
SCHOEFFTER, P ;
HOYER, D ;
LUBBERT, H .
MOLECULAR AND CELL BIOLOGICAL ASPECTS OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR DISEASE, 1994, 733 :138-146
[7]  
BRUNS C, 1996, METAB CLIN EXP, V44, P17
[8]   SYNTHESIS AND BIOLOGICAL-ACTIVITY OF HIGHLY POTENT OCTAPEPTIDE ANALOGS OF SOMATOSTATIN [J].
CAI, RZ ;
SZOKE, B ;
LU, R ;
FU, D ;
REDDING, TW ;
SCHALLY, AV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) :1896-1900
[9]   Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5 [J].
Contour-Galcéra, MO ;
Poitout, L ;
Moinet, C ;
Morgan, B ;
Gordon, T ;
Roubert, P ;
Thurieau, C .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (05) :741-745
[10]  
COY DH, 1996, METABOLISM S1, V34, P21